News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
236,365 Results
Type
Article (7653)
Company Profile (51)
Press Release (228661)
Multimedia
Podcasts (4)
Webinars (2)
Section
Business (72458)
Career Advice (219)
Deals (15774)
Drug Delivery (11)
Drug Development (30984)
Employer Resources (13)
FDA (5191)
Job Trends (5449)
News (123248)
Policy (10714)
Tag
Academia (803)
Accelerated approval (4)
Adcomms (1)
Allergies (34)
Alliances (12310)
ALS (42)
Alzheimer's disease (563)
Antibody-drug conjugate (ADC) (63)
Approvals (5350)
Artificial intelligence (74)
Autoimmune disease (16)
Automation (5)
Bankruptcy (120)
Best Places to Work (4984)
BIOSECURE Act (3)
Biosimilars (18)
Biotechnology (32)
Bladder cancer (47)
Brain cancer (12)
Breast cancer (196)
Cancer (1389)
Cardiovascular disease (115)
Career advice (195)
Career pathing (4)
CAR-T (80)
CDC (2)
Cell therapy (180)
Cervical cancer (12)
Clinical research (26785)
Collaboration (306)
Company closure (1)
Compensation (237)
Complete response letters (6)
COVID-19 (1177)
CRISPR (19)
C-suite (102)
Cystic fibrosis (41)
Data (1922)
Denatured (1)
Depression (40)
Diabetes (136)
Diagnostics (2457)
Digital health (13)
Diversity, equity & inclusion (1)
Drug discovery (36)
Drug pricing (10)
Drug shortages (3)
Duchenne muscular dystrophy (56)
Earnings (46387)
Editorial (9)
Employer branding (3)
Employer resources (13)
Events (39554)
Executive appointments (179)
FDA (6197)
Fibrodysplasia Ossificans Progressiva (2)
Frontotemporal dementia (6)
Funding (247)
Gene editing (41)
Generative AI (3)
Gene therapy (104)
GLP-1 (234)
Government (1610)
Grass and pollen (2)
Guidances (289)
Healthcare (7532)
HIV (16)
Huntington's disease (11)
IgA nephropathy (13)
Immunology and inflammation (55)
Immuno-oncology (1)
Indications (22)
Infectious disease (1249)
Inflammatory bowel disease (62)
Influenza (31)
Intellectual property (59)
Interviews (31)
IPO (10406)
IRA (3)
Job creations (667)
Job search strategy (167)
Kidney cancer (5)
Labor market (17)
Layoffs (105)
Leadership (3)
Legal (2071)
Liver cancer (31)
Longevity (4)
Lung cancer (210)
Lymphoma (107)
Machine learning (7)
Management (5)
Manufacturing (109)
MASH (61)
Medical device (5521)
Medtech (5525)
Mergers & acquisitions (5712)
Metabolic disorders (322)
Multiple sclerosis (43)
NASH (10)
Neurodegenerative disease (60)
Neuropsychiatric disorders (12)
Neuroscience (853)
NextGen: Class of 2025 (1702)
Non-profit (1361)
Now hiring (6)
Obesity (127)
Opinion (21)
Ovarian cancer (52)
Pain (42)
Pancreatic cancer (64)
Parkinson's disease (55)
Partnered (6)
Patents (116)
Patient recruitment (83)
Peanut (19)
People (14324)
Pharmaceutical (12)
Pharmacy benefit managers (1)
Phase I (7559)
Phase II (11674)
Phase III (9952)
Pipeline (1565)
Policy (18)
Postmarket research (889)
Preclinical (2794)
Press Release (15)
Prostate cancer (68)
Psychedelics (6)
Radiopharmaceuticals (108)
Rare diseases (172)
Real estate (1245)
Recruiting (7)
Regulatory (8166)
Reports (11)
Research institute (633)
Resumes & cover letters (21)
Rett syndrome (4)
RNA editing (2)
RSV (22)
Schizophrenia (49)
Series A (37)
Series B (31)
Service/supplier (6)
Sickle cell disease (21)
Special edition (10)
Spinal muscular atrophy (81)
Sponsored (5)
Startups (665)
State (1)
Stomach cancer (1)
Supply chain (25)
Tariffs (12)
The Weekly (3)
Vaccines (240)
Venture capital (15)
Weight loss (54)
Women's health (9)
Worklife (2)
Date
Today (86)
Last 7 days (240)
Last 30 days (717)
Last 365 days (11527)
2025 (8908)
2024 (13243)
2023 (15223)
2022 (18850)
2021 (20145)
2020 (41848)
2019 (15554)
2018 (10708)
2017 (10568)
2016 (8599)
2015 (11203)
2014 (7513)
2013 (5238)
2012 (6055)
2011 (6579)
2010 (5737)
Location
Africa (140)
Alabama (32)
Alaska (1)
Arizona (54)
Arkansas (1)
Asia (14311)
Australia (2068)
California (3526)
Canada (827)
China (283)
Colorado (162)
Connecticut (182)
Delaware (136)
Europe (29245)
Florida (528)
Georgia (91)
Idaho (11)
Illinois (242)
India (9)
Indiana (187)
Iowa (3)
Japan (106)
Kansas (66)
Kentucky (7)
Louisiana (9)
Maine (28)
Maryland (390)
Massachusetts (2319)
Michigan (89)
Minnesota (181)
Mississippi (1)
Missouri (53)
Montana (8)
Nebraska (6)
Nevada (22)
New Hampshire (22)
New Jersey (1192)
New Mexico (6)
New York (980)
North Carolina (374)
North Dakota (5)
Northern California (1671)
Ohio (85)
Oklahoma (2)
Oregon (6)
Pennsylvania (788)
Puerto Rico (1)
Rhode Island (5)
South America (259)
South Carolina (9)
Southern California (1389)
Tennessee (21)
Texas (531)
United States (12468)
Utah (93)
Virginia (95)
Washington D.C. (7)
Washington State (267)
West Virginia (1)
Wisconsin (15)
236,365 Results for "21".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
Chiesi, Arbor Weave $2.1B Rare Disease Pact
The centerpiece of the collaboration is the gene editor ABO-101, being developed for primary hyperoxaluria type 1, a rare disease that leads to severe kidney stones.
October 6, 2025
·
1 min read
·
Tristan Manalac
Press Releases
Elutia to Present at the LD Micro Main Event XIX Conference on Tuesday, October 21
October 15, 2025
·
1 min read
Press Releases
NEXGEL to Present at the LD Micro Main Event XIX Conference on October 19-21
October 10, 2025
·
1 min read
Press Releases
Aerska Launches with $21 Million in Financing to Develop RNAi Medicines for Diseases of the Brain
October 1, 2025
·
3 min read
Rare diseases
Novo Offers up to $2.1B for Omeros’ Complement Drug To Expand Rare Disease Work
Novo Nordisk strikes another deal, this time with Omeros, amid a broader pipeline restructuring that recently claimed its cell therapy work.
October 15, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Averto Medical Awarded $2.1 Million NIH Grant to Advance Breakthrough Therapy for Diverticulitis
October 7, 2025
·
3 min read
Press Releases
Quest Diagnostics to Release Third Quarter 2025 Financial Results on October 21, 2025
September 26, 2025
·
1 min read
Press Releases
Certara Launches Pinnacle 21® Enterprise Plus to Deliver Regulatory Submissions Faster
September 5, 2025
·
2 min read
Press Releases
Novo Nordisk to acquire Akero Therapeutics and its promising phase 3 FGF21 analogue to expand MASH portfolio
October 9, 2025
·
7 min read
Press Releases
Alkeus Pharmaceuticals Announces Presentation of Gildeuretinol Data at the American Academy of Ophthalmology (AAO) 2025 Annual Meeting, October 18-21 in Orlando
October 10, 2025
·
2 min read
1 of 23,637
Next
